Article,

CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group

, , , , , , , , , , , , , , , , , , , , and .
The Lancet Oncology, 12 (11): 1013–1022 (2011)

Meta data

Tags

Users

  • @drtester

Comments and Reviews